Table 3.
Groups | FBG level (mg/dl) |
||||
---|---|---|---|---|---|
0 h | 1st h | 2nd h | 3rd h | 4th h | |
NC | 286.00 ± 12.9a3 | 284.00 ± 13.60Ac | 277.80 ± 13.88 Ac | 274.60 ± 13.80Ac | 269.00 ± 14.20Ac |
NOC | 91.6 ± 1.16 | 90.00 ± 0.94 | 87.80 ± 1.31 | 84.80 ± 0.66 | 83.44 ± 0.87 |
GL5 | 280.60 ± 18.10Ac | 239.20 ± 12.80Ac | 186.60 ± 13.55 AaBa | 175.00 ± 11.26 AaBb | 133.00 ± 8.56 Bc |
RELE100 | 284.00 ± 21.38Ac | 266.00 ± 20.96 Ac | 259.20 ± 18.02 Ac | 230.00 ± 21.05 Ac | 202.60 ± 29.80 Ab |
RELE200 | 298.80 ± 24.92Ac | 258.60 ± 26.70 Ac |
239.20 ± 36.87 Ac | 190.80 ± 27.93 AbBa |
186.40 ± 26.50 AbBa |
RELE400 | 297.80 ± 13.70a3 | 252.00 ± 17.42 Ac | 200 ± 13.50Ab | 173.20 ± 12.99AaBa | 154.20 ± 12.06Ba |
Each value represents mean ± S.E.M; n = 6; Analysis was performed by one way ANOVA; Acompared to normal control; Bcompared to negative control; number followed by RELE and GL indicates dose in mg/kg; ap < 0.05; bp < 0.01; cp < 0.001.
Abbreviations: NOC, normal control; NC, negative control; GL, glibenclamide; RELE, Rubus erlangeri leaf extract.